Douglas Logan

Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol

Evan A. Stein, Scott Mellis, George D. Yancopoulos et al. · New England Journal of Medicine · 2012 · 664 citations · Full text

Life Sciences, Cardiology, Pharmacotherapy +17

Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus

Deepak L. Bhatt, Jing-fei Dong, Douglas Logan et al. · Journal of the American College of Cardiology · 2017 · 147 citations

Medicine, Internal Medicine, Pharmaceutics +15

The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Paul A. Gurbel, Kevin P. Bliden, Douglas Logan et al. · Journal of the American College of Cardiology · 2013 · 138 citations

Medicine, Pharmacokinetics, Pharmacology +8

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease

Matthew J. Price, James Walder, Brian Baker et al. · Journal of the American College of Cardiology · 2012 · 116 citations

Medicine, Cardiology, Hematology +15

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

Robert R. Henry, Julio Rosenstock, Douglas Logan et al. · Journal of Diabetes and its Complications · 2014 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17